Intravesical prostatic protrusion predict the response to α-blocker in patients with BPH

HAN Wenke,SHAN Gangzhi,JIN Jie
DOI: https://doi.org/10.3969/j.issn.1672-1993.2010.03.003
2010-01-01
Abstract:Objectives:We investigate the relationship between the response to α-blocker and the degree of intravesical prostatic protrusion (IPP) in patients with BPH. Methods:Consecutive 86 outpatients with BPH presented with lower urinary tract symptoms received 2mg of terazosin,once a day for 4 weeks. The length of IPP was measured in the mid sagittal section by transabdominal ultrasound. The patients were divided into 3 groups based on their IPP degree. The relationship of IPP degree with the improvement of international prostatic symptom score (IPSS),the maximum uroflow rate (Qmax),and the postvoid residual urine volume (PVR) were analyzed. Results:After 4 weeks α-blocker therapy,both IPSS (decreased by 5.5,P<0.05) and Qmax (increased by 3.2 ml/s,P<0.05) were significantly improved in 42 patients with IPP < 5 mm; only IPSS (decreased by 5.1,P<0.05) significantly improved in 26 patients with IPP 5~10mm; there were no significantly improved parameters in 18 patients with IPP≥10 mm. Conclusions:The results of the present study suggest that the degree of IPP measured by transabdominal ultrasound appears to predict the response to α-blocker in patients with BPH. The treatment of α-blocker is more likely to fail in patients with IPP≥10 mm.
What problem does this paper attempt to address?